Veracyte (VCYT) Share-based Compensation (2014 - 2026)

Veracyte has disclosed Share-based Compensation across 13 years of filings, most recently posting $12.8 million for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $12.8 million, up 16.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.4 million (up 15.86% YoY), and the FY2025 annual result was $43.6 million, up 20.28% from the prior year.
• Share-based Compensation came in at $12.8 million for Q1 2026 at Veracyte, up from $10.9 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $12.8 million in Q1 2026 to a low of $5.9 million in Q2 2022.
• The 5-year median for Share-based Compensation is $8.7 million (2024), against an average of $9.0 million.
• Across the five-year window, Share-based Compensation fell 7.44% in 2022 and soared 74.79% in 2023, its largest moves.
• Veracyte's Share-based Compensation stood at $6.9 million in 2022, then increased by 9.39% to $7.5 million in 2023, then grew by 28.18% to $9.6 million in 2024, then advanced by 13.21% to $10.9 million in 2025, then climbed by 17.06% to $12.8 million in 2026.
• The last three Share-based Compensation figures came in at $12.8 million (Q1 2026), $10.9 million (Q4 2025), and $10.8 million (Q3 2025), per Business Quant data.